Toll Free 1-877-6-ROCHEM / Fax 631-738-1199

Rx Active Pharmaceutical Ingredients – In Development

Human Oral
  • Apixaban
  • Canagliflozin
  • Celecoxib
  • Dabigatran Etexilate Mesylate
  • Deferasirox
  • Erlotinib
  • Fidaxomicin
  • Lenalidomide
  • Linaclotide
  • Linagliptin
  • Nilotinib HCl
  • Pomalidomide
  • Rivaroxaban
  • Ticagrelor
Human Injectables
  • Cetrorelix Acetate
  • Degarelix Acetate (available for EU only)
  • Fondaparinux Na
  • Fosaprepitant Dimeglumine
  • Icatibant Acetate
  • Liraglutide
  • Micafungin Na
  • Sincalide
  • Teduglutide
  • Telavancin HCl
  • Teriparatide
  • Ziconotide Acetate

All product listed which is covered under current patents is available only for use reasonably related to the development and submission of information to the related Health Authorities (including the US FDA) to the extent permitted under applicable laws regulating the manufacture use and sales of Active Pharmaceutical Ingredients and/or their intermediates.

*These products are in various stages of “investigation”, all regulatory/compliance/process specific information may not be available.